End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 EUR | -.--% | -.--% | -.--% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- OVXA Stock
- OVXA Stock
- News Ovoca Bio plc
- Ovoca Bio Gains 13% on Completed Patient Enrollment in Mid-stage Study of Sexual Disorder Drug